25 July 2022>: Database Analysis
Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (−)-Guaiol Against Lung Adenocarcinoma
Yaoying Zeng 1E* , Yanbin Pan 1B* , Bo Zhang 1C , Yingbin Luo 1D , Jianhui Tian 1AF , Yuli Wang 1CD , Xudong Ju 2BF , Jianchun Wu 1A* , Yan Li 1A*DOI: 10.12659/MSM.937131
Med Sci Monit 2022; 28:e937131
Figure 1 In the flow chart, the systems pharmacology approach was used to determine the mechanism of (−)-Guaiol in the treatment of LUAD by integrating target identification, network construction, enrichment analysis, molecular docking and experimental validations.